Single Nucleotide Polymorphism Microarray Analysis in Cortisol-Secreting Adrenocortical Adenomas Identifies New Candidate Genes and Pathways

Mansmann, 2004, The clinically in apparent adrenal mass: update in diagnosis and management, Endocr Rev, 25, 309, 10.1210/er.2002-0031 Fassnacht, 2011, Adrenocortical carcinoma: a clinician's update, Nat Rev Endocrinol, 7, 323, 10.1038/nrendo.2010.235 Bernard, 2003, A case report in favor of a multistep adrenocortical tumorigenesis, J Clin Endocrinol Metab, 88, 998, 10.1210/jc.2002-021117 Barzon, 2003, Prevalence and natural history of adrenal incidentalomas, Eur J Endocrinol, 149, 273, 10.1530/eje.0.1490273 Bassett, 2005, Expression profiles for steroidogenic enzymes in adrenocortical disease, J Clin Endocrinol Metab, 90, 5446, 10.1210/jc.2005-0836 Lindholm, 2001, Incidence and late prognosis of Cushing's syndrome: a population-based study, J Clin Endocrinol Metab, 86, 117 Ragazzon, 2011, Transcriptome analysis of adrenocortical cancers: from molecular classification to the identification of new treatments, Endocr Relat Cancer, 18, R15 Stratakis, 2009, New genes and/or molecular pathways associated with adrenal hyperplasias and related adrenocortical tumors, Mol Cell Endocrinol, 300, 152, 10.1016/j.mce.2008.11.010 Sidhu, 2003, Clinical and molecular aspects of adrenocortical tumourigenesis, ANZ J Surg, 73, 727, 10.1046/j.1445-2197.2003.02746.x Gicquel, 2001, Molecular markers and long-term recurrences in a large cohort of patients with sporadic adrenocortical tumors, Cancer Res, 61, 6762 Bonnet, 2011, Wnt/β-catenin pathway activation in adrenocortical adenomas is frequently due to somatic CTNNB1-activating mutations, which are associated with larger and nonsecreting tumors: a study in cortisol-secreting and -nonsecreting tumors, J Clin Endocrinol Metab, 96, E419, 10.1210/jc.2010-1885 Gaujoux, 2011, β-Catenin activation is associated with specific clinical and pathologic characteristics and a poor outcome in adrenocortical carcinoma, Clin Cancer Res, 17, 328, 10.1158/1078-0432.CCR-10-2006 Tadjine, 2008, Frequent mutations of β-catenin gene in sporadic secreting adrenocortical adenomas, Clin Endocrinol (Oxf), 68, 264 Dohna, 2000, Adrenocortical carcinoma is characterized by a high frequency of chromosomal gains and high-level amplifications, Genes Chromosomes Cancer, 28, 145, 10.1002/(SICI)1098-2264(200006)28:2<145::AID-GCC3>3.0.CO;2-7 Sidhu, 2002, Comparative genomic hybridization analysis of adrenocortical tumors, J Clin Endocrinol Metab, 87, 3467, 10.1210/jcem.87.7.8697 Zhao, 1999, Analysis of genomic alterations in sporadic adrenocortical lesions. Gain of chromosome 17 is an early event in adrenocortical tumorigenesis, Am J Pathol, 155, 1039, 10.1016/S0002-9440(10)65205-4 Gruschwitz, 2010, Improvement of histopathological classification of adrenal gland tumors by genetic differentiation, World J Urol, 28, 329, 10.1007/s00345-010-0541-7 Kjellman, 1996, Genetic aberrations in adrenocortical tumors detected using comparative genomic hybridization correlate with tumor size and malignancy, Cancer Res, 56, 4219 Zhao, 2002, Combined comparative genomic hybridization and genomic microarray for detection of gene amplifications in pulmonary artery intimal sarcomas and adrenocortical tumors, Genes Chromosomes Cancer, 34, 48, 10.1002/gcc.10035 Stephan, 2008, Adrenocortical carcinoma survival rates correlated to genomic copy number variants, Mol Cancer Ther, 7, 425, 10.1158/1535-7163.MCT-07-0267 Szabo, 2010, Meta-analysis of adrenocortical tumour genomics data: novel pathogenic pathways revealed, Oncogene, 29, 3163, 10.1038/onc.2010.80 LaFramboise, 2009, Single nucleotide polymorphism arrays: a decade of biological, computational and technological advances, Nucleic Acids Res, 37, 4181, 10.1093/nar/gkp552 Bignell, 2004, High-resolution analysis of DNA copy number using oligonucleotide microarrays, Genome Res, 14, 287, 10.1101/gr.2012304 Dutt, 2007, Single nucleotide polymorphism array analysis of cancer, Curr Opin Oncol, 19, 43, 10.1097/CCO.0b013e328011a8c1 Nieman, 2008, The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline, J Clin Endocrinol Metab, 93, 1526, 10.1210/jc.2008-0125 Fassnacht, 2010, Arterial hypertension and subclinical Cushing's syndrome [in German], MMW Fortschr Med, 152, 39, 10.1007/BF03366115 Cheung, 2010, High resolution analysis of follicular lymphoma genomes reveals somatic recurrent sites of copy-neutral loss of heterozygosity and copy number alterations that target single genes, Genes Chromosomes Cancer, 49, 669, 10.1002/gcc.20780 Choy, 2010, The impact of human copy number variation on a new era of genetic testing, BJOG, 117, 391, 10.1111/j.1471-0528.2009.02470.x Benjamini, 1995, Controlling the false discovery rate—a practical and powerful approach to multiple testing, J R Stat Soc B Met, 57, 289 Jensen, 2009, STRING 8—a global view on proteins and their functional interactions in 630 organisms, Nucleic Acids Res, 37, D412, 10.1093/nar/gkn760 Szklarczyk, 2011, The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored, Nucleic Acids Res, 39, D561, 10.1093/nar/gkq973 Haralambieva, 2002, Detection of three common translocation breakpoints in non-Hodgkin's lymphomas by fluorescence in situ hybridization on routine paraffin-embedded tissue sections, J Pathol, 198, 163, 10.1002/path.1197 LeBron, 2011, Genome-wide analysis of genetic alterations in testicular primary seminoma using high resolution single nucleotide polymorphism arrays, Genomics, 97, 341, 10.1016/j.ygeno.2011.02.011 Toma, 2008, Loss of heterozygosity and copy number abnormality in clear cell renal cell carcinoma discovered by high-density Affymetrix 10K single nucleotide polymorphism mapping array, Neoplasia, 10, 634, 10.1593/neo.08160 Chari, 2010, An integrative multi-dimensional genetic and epigenetic strategy to identify aberrant genes and pathways in cancer, BMC Syst Biol, 4, 67, 10.1186/1752-0509-4-67 Pfaffl, 2001, A new mathematical model for relative quantification in real-time RT-PCR, Nucleic Acids Res, 29, e45, 10.1093/nar/29.9.e45 Sbiera, 2010, High diagnostic and prognostic value of steroidogenic factor-1 expression in adrenal tumors, J Clin Endocrinol Metab, 95, E161, 10.1210/jc.2010-0653 Lobry, 2011, Oncogenic and tumor suppressor functions of Notch in cancer: it's NOTCH what you think, J Exp Med, 208, 1931, 10.1084/jem.20111855 Almeida, 2008, Expression of insulin-like growth factor-II and its receptor in pediatric and adult adrenocortical tumors, J Clin Endocrinol Metab, 93, 3524, 10.1210/jc.2008-0065 Yashiro, 1994, Point mutations of ras genes in human adrenal cortical tumors: absence in adrenocortical hyperplasia, World J Surg, 18, 455, 10.1007/BF00353735 Patterson, 2011, Micro-RNA profiling of adrenocortical tumors reveals miR-483 as a marker of malignancy, Cancer, 117, 1630, 10.1002/cncr.25724 Schmitz, 2011, Differential expression of microRNA-675, microRNA-139-3p and microRNA-335 in benign and malignant adrenocortical tumours, J Clin Pathol, 64, 529, 10.1136/jcp.2010.085621 Pasquale, 2010, Eph receptors and ephrins in cancer: bidirectional signalling and beyond, Nat Rev Cancer, 10, 165, 10.1038/nrc2806 El Wakil, 2011, The Wnt/β-catenin pathway in adrenocortical development and cancer, Mol Cell Endocrinol, 332, 32, 10.1016/j.mce.2010.11.014 Artunc, 2008, Lack of the serum and glucocorticoid-inducible kinase SGK1 attenuates the volume retention after treatment with the PPAR. agonist pioglitazone, Pflugers Arch, 456, 425, 10.1007/s00424-007-0401-5 Amato, 2009, Sgk1 activates MDM2-dependent p53 degradation and affects cell proliferation, survival, and differentiation, J Mol Med (Berl), 87, 1221, 10.1007/s00109-009-0525-5 Lang, 2010, Colorectal carcinoma cells—regulation of survival and growth by SGK1, Int J Biochem Cell Biol, 42, 1571, 10.1016/j.biocel.2010.05.016 Reiter, 2011, Opposite effects of serum-and glucocorticoid-regulated kinase-1 and glucocorticoids on POMC transcription and ACTH release, Am J Physiol Endocrinol Metab, 301, E336, 10.1152/ajpendo.00155.2011 Miyata, 2011, Plasma corticosterone activates SGK1 and induces morphological changes in oligodendrocytes in corpus callosum, PLoS One, 6, e19859, 10.1371/journal.pone.0019859 Lang, 2006, (Patho)physiological significance of the serum- and glucocorticoid-inducible kinase isoforms, Physiol Rev, 86, 1151, 10.1152/physrev.00050.2005 Tyybakinoja, 2008, Single nucleotide polymorphism microarray analysis of karyotypically normal acute myeloid leukemia reveals frequent copy number neutral loss of heterozygosity, Haematologica, 93, 631, 10.3324/haematol.12232 Hayward, 2005, Notch modulates Wnt signalling by associating with Armadillo/β-catenin and regulating its transcriptional activity, Development, 132, 1819, 10.1242/dev.01724 Balint, 2005, Activation of Notch1 signaling is required for β-catenin-mediated human primary melanoma progression, J Clin Invest, 115, 3166, 10.1172/JCI25001 Failor, 2007, Glucocorticoid-induced degradation of glycogen synthase kinase-3 protein is triggered by serum- and glucocorticoid-induced protein kinase and Akt signaling and controls β-catenin dynamics and tight junction formation in mammary epithelial tumor cells, Mol Endocrinol, 21, 2403, 10.1210/me.2007-0143 Mo, 2011, Serum-and glucocorticoid-inducible kinase 1 (SGK1) controls Notch1 signaling by downregulation of protein stability through Fbw7 ubiquitin ligase, J Cell Sci, 124, 100, 10.1242/jcs.073924